|
22
|
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
PAR-25-096 · National Institutes of Health · applied research
|
biomedical clinical
ai data science
public health
|
$200,000 |
2024-11-18 |
2026-11-17 |
133 |
|
18
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
PAR-25-075 · National Institutes of Health · applied research
|
biomedical clinical
public health
computing communications
|
$250,000 |
2024-10-15 |
2026-10-14 |
99 |
|
18
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
PAR-24-027 · National Institutes of Health · applied research
|
public health
biomedical clinical
mental behavioral health
|
— |
2023-08-24 |
2026-10-30 |
115 |
|
12
|
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
RFA-NS-25-022 · National Institutes of Health · applied research
|
biomedical clinical
public health
ai data science
|
— |
2024-11-05 |
2026-09-28 |
83 |
|
12
|
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
RFA-NS-25-021 · National Institutes of Health · applied research
|
biomedical clinical
public health
materials manufacturing
|
— |
2024-11-05 |
2026-09-28 |
83 |
|
12
|
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
PA-23-317 · National Institutes of Health · applied research
|
biomedical clinical
public health
ai data science
|
— |
2023-11-24 |
2026-11-24 |
140 |
|
5
|
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
PAR-23-284 · National Institutes of Health · applied research
|
biomedical clinical
public health
computing communications
|
— |
2023-09-22 |
2026-09-25 |
80 |
|
3
|
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
PAR-24-306 · National Institutes of Health · applied research
|
biomedical clinical
cybersecurity
computing communications
|
$499,000 |
2024-11-06 |
2026-09-07 |
62 |
|
2
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
PAR-25-074 · National Institutes of Health · applied research
|
biomedical clinical
public health
ai data science
|
— |
2024-10-15 |
2026-10-14 |
99 |
|
0
|
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
PAR-24-304 · National Institutes of Health · applied research
|
biomedical clinical
computing communications
public health
|
— |
2024-10-10 |
2026-10-14 |
99 |